Director David J. Brailer filed a Form 3 initial statement of beneficial ownership with the SEC on November 12, 2026, reporting his status as a newly affiliated director of Teva Pharmaceutical Industries Ltd. as of November 3, 2026.
Key Highlights
- Reporting person: David J. Brailer, listed as a Director of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA)
- Triggering event date: November 3, 2026, identified as the date of the event requiring the statement
- No securities held: The filing states "No securities are beneficially owned" in both Table I (non-derivative) and Table II (derivative securities)
- Filing date: The form was signed and filed on November 12, 2026, by Dov Bergwerk as attorney-in-fact for David J. Brailer
- Filing type: Individual filing by one reporting person, not a joint or group filing
Brailer Reports No Beneficial Ownership Upon Joining Teva Board
According to the filing, David J. Brailer submitted a Form 3 initial statement of beneficial ownership in connection with becoming a Director of Teva Pharmaceutical Industries Ltd., traded on the New York Stock Exchange under the symbol TEVA. The event requiring the statement occurred on November 3, 2026, with the form subsequently filed on November 12, 2026.
The filing discloses that Brailer holds no beneficial ownership of any securities of the issuer at the time of the initial statement. Both Table I, covering non-derivative securities, and Table II, covering derivative securities such as puts, calls, warrants, options, and convertible securities, were left blank. The filing includes the explicit explanation: "No securities are beneficially owned."
The form was signed by Dov Bergwerk as attorney-in-fact for David J. Brailer. Brailer's address of record is listed as c/o Teva Pharmaceutical Industries Ltd., 124 Dvora HaNevi'a St., Tel Aviv, Israel 6944020. The filing was submitted by one reporting person and was not a joint or group filing.
What Was Disclosed
David J. Brailer, a newly appointed Director at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), filed an initial beneficial ownership statement reporting no direct or indirect holdings of any company securities as of the November 3, 2026 triggering event date.



Please wait processing your request...